Skip to content

Screening specific antibodies against FIX from Hemophilia B patients with inhibitors and exploring its application in anticoagulation therapy

Screening specific antibodies against FIX from Hemophilia B patients with inhibitors and exploring its application in anticoagulation therapy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102558
Enrollment
Unknown
Registered
2025-05-16
Start date
2025-05-20
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemophilia B

Interventions

Sponsors

Beijing Children’s Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
1 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1 Severe hemophilia B, baseline FIX:C =0.6BU). 3 Age <18 years old.

Exclusion criteria

Exclusion criteria: 1 Has a history of autoimmune disease or positive for autoantibodies. 2 Has a clear history of infection and vaccination within 3 months prior to blood collection. 3 Has other gene mutations related to coagulation.

Design outcomes

Primary

MeasureTime frame
inhibitor;

Secondary

MeasureTime frame
FIX:C;

Countries

China

Contacts

Public ContactRunhui Wu

Beijing Children’s Hospital, Capital Medical University

runhuiwu@hotmail.com+86 139 1138 3480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026